{
  "ticker": "LH",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T09:55:23.615356",
  "count": 102,
  "transactions": [
    {
      "id": 53206,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 73955,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 96801,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 121810,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 148797,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 177900,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 209478,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 243596,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 281596,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 324898,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 34953,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 53207,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 73956,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 96802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 121811,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 148798,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 177901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 209479,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 243597,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 281597,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 324899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 34908,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 34939,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 53161,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 53192,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 73910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 73941,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 96753,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 96785,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 121762,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 121794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 148748,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 148781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 177847,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 177883,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 209422,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 209460,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 243539,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 243577,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 281502,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 281568,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 324794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 324867,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 34924,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 53177,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 73926,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 96770,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 121779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 148766,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 177868,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 209444,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 243561,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 281535,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 324830,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 20319,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 34911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 53164,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 73913,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 96756,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 121765,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 148751,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 177850,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 209425,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 243542,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 281506,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 324798,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 20307,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 20321,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 20346,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 34898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 34913,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 34940,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 53151,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 53166,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 53193,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 73900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 73915,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 73942,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 96742,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 96758,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 96786,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 121751,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 121767,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 121795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 148737,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 148753,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 148782,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 177836,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 177853,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 177884,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 209411,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 209429,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 209461,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 243528,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 243546,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 243578,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 281486,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 281512,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 281569,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 324777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 324804,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 324868,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    }
  ]
}